RESIST
A Study on the Best Course of Action Following Immunotherapy for Early-Stage Malignant Tumors of the Digestive Tract (Esophagus, Stomach, or Intestine)
The RESIST study is investigating the safety and efficacy of a structured, non-surgical management approach compared to the established standard surgical treatment.
Clinics
-
Luzerner Kantonsspital AG
-
St. Claraspital AG